...
首页> 外文期刊>Chemical research in toxicology >Cytochrome b 5 increases cytochrome P450 3A4-mediated activation of anticancer drug ellipticine to 13-hydroxyellipticine whose covalent binding to DNA is elevated by sulfotransferases and N,O-acetyltransferases
【24h】

Cytochrome b 5 increases cytochrome P450 3A4-mediated activation of anticancer drug ellipticine to 13-hydroxyellipticine whose covalent binding to DNA is elevated by sulfotransferases and N,O-acetyltransferases

机译:细胞色素b 5增加了细胞色素P450 3A4介导的抗癌药物玫瑰树碱向13-羟基玫瑰树碱的活化,其与DNA的共价结合被磺基转移酶和N,O-乙酰基转移酶增强

获取原文
获取原文并翻译 | 示例

摘要

The antineoplastic alkaloid ellipticine is a prodrug, whose pharmacological efficiency is dependent on its cytochrome P450 (P450)- and/or peroxidase-mediated activation in target tissues. The P450 3A4 enzyme oxidizes ellipticine to five metabolites, mainly to 13-hydroxy- and 12- hydroxyellipticine, the metabolites responsible for the formation of ellipticine-13-ylium and ellipticine-12-ylium ions that generate covalent DNA adducts. Cytochrome b 5 alters the ratio of ellipticine metabolites formed by P450 3A4. While the amounts of the detoxication metabolites (7-hydroxy- and 9-hydroxyellipticine) were not changed with added cytochrome b 5, 12-hydroxy- and 13-hydroxyellipticine, and ellipticine N 2-oxide increased considerably. The P450 3A4-mediated oxidation of ellipticine was significantly changed only by holo-cytochrome b 5, while apo-cytochrome b 5 without heme or Mn-cytochrome b 5 had no such effect. The change in amounts of metabolites resulted in an increased formation of covalent ellipticine-DNA adducts, one of the DNA-damaging mechanisms of ellipticine antitumor action. The amounts of 13-hydroxy- and 12-hydroxyellipticine formed by P450 3A4 were similar, but more than 7-fold higher levels of the adduct were formed by 13-hydroxyellipticine than by 12-hydroxyellipticine. The higher susceptibility of 13-hydroxyellipticine toward heterolytic dissociation to ellipticine-13-ylium in comparison to dissociation of 12-hydroxyellipticine to ellipticine-12-ylium, determined by quantum chemical calculations, explains this phenomenon. The amounts of the 13- hydroxyellipticine-derived DNA adduct significantly increased upon reaction of 13-hydroxyellipticine with either 3′-phosphoadenosine-5′- phosphosulfate or acetyl-CoA catalyzed by human sulfotransferases 1A1, 1A2, 1A3, and 2A1, or N,O-acetyltransferases 1 and 2. The calculated reaction free energies of heterolysis of the sulfate and acetate esters are by 10-17 kcal/mol more favorable than the energy of hydrolysis of 13-hydroxyellipticine, which could explain the experimental data.
机译:抗肿瘤生物碱玫瑰树碱是一种前药,其药理效率取决于其在靶组织中的细胞色素P450(P450)和/或过氧化物酶介导的活化。 P450 3A4酶将玫瑰树碱氧化为5种代谢物,主要氧化为13-羟基和12-羟基玫瑰树碱,这些代谢物负责形成玫瑰树碱13-ylium和玫瑰树碱12-ylium离子,并生成共价DNA加合物。细胞色素b 5改变了由P450 3A4形成的玫瑰树碱代谢产物的比例。尽管添加的细胞色素b 5、12-羟基和13-羟基玫瑰树碱的脱毒代谢物(7-羟基和9-羟基玫瑰树碱)的量没有变化,玫瑰树碱N 2-氧化物大大增加。 P450 3A4介导的玫瑰树碱的氧化作用仅由完整细胞色素b 5显着改变,而不含血红素的脱辅基细胞色素b 5或Mn细胞色素b 5则无此作用。代谢物数量的变化导致玫瑰树碱抗肿瘤作用的DNA破坏机制之一,玫瑰树碱-DNA共价共价物形成增加。由P450 3A4形成的13-羟基玫瑰树碱和12-羟基玫瑰树碱的量相似,但13-羟基玫瑰树碱形成的加合物的水平比12-羟基玫瑰树碱高7倍以上。与通过量子化学计算确定的12-羟基玫瑰树碱解离为玫瑰树碱-12-基团相比,13-羟基玫瑰树碱对解溶解为玫瑰树碱-13-基团的敏感性更高。 13-羟基玫瑰树碱与人磺基转移酶1A1、1A2、1A3和2A1或N催化的3'-磷酸腺苷-5'-磷酸硫酸盐或乙酰辅酶A反应后,13-羟基玫瑰树碱衍生的DNA加合物的量显着增加。 O-乙酰基转移酶1和2。计算得出的硫酸酯和乙酸酯杂化反应的自由能比13-羟基玫瑰树碱的水解能高10-17 kcal / mol,这可以解释实验数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号